Drawing based on the label description. No photo yet.
W 22 pill
Pill with imprint W 22 is white, round, 12 mm and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride 8 mg / 2 mg. It is used for opioid use disorder. It is supplied by Asclemed Usa, Inc.
Controlled substance: Schedule III
Buprenorphine Hydrochloride and Naloxone Hydrochloride 8 mg / 2 mg
- Imprint
- W 22
- Strength
- Buprenorphine 8 mg / Naloxone 2 mg
- Used for
- Opioid use disorder
- Color
- White
- Shape
- Round
- Size
- 12 mm
- Score
- No score line
- Form
- Tablet
- Manufacturer
- Asclemed Usa, Inc
- Drug class
- Partial opioid (pain or opioid use disorder medicine)
- NDC
- 76420-534, 16729-550, 76420-534-30, 16729-550-10, 71335-1858, 71335-1858-7, 71335-1858-8, 71335-1858-6, 71335-1858-5, 71335-1858-9, 71335-1858-0, 71335-1858-1, 71335-1858-2, 71335-1858-3, 71335-1858-4, 67296-2191, 67296-2191-1, 67296-2191-6
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Buprenorphine and Naloxone used for?
Buprenorphine and Naloxone is used for opioid use disorder.
- Medicine type
- Partial opioid (pain or opioid use disorder medicine); opioid blocker
Official uses from the US prescribing label
Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support.
From the FDA-approved label on DailyMed (published Aug 13, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows W 22. The parts can be split between the two sides, so turn the pill over and check both.
- It is white, round, 12 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate.
Ingredients
Active: Buprenorphine Hydrochloride, Naloxone Hydrochloride Dihydrate
Inactive: Anhydrous Citric Acid, Crospovidone, Lactose Monohydrate, Magnesium Stearate, Mannitol, Starch, Corn, Povidone, Sodium Citrate, Sucralose
Also distributed by
Accord Healthcare, Inc, Bryant Ranch Prepack, Redpharm Drug
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
AA 16
Desipramine 150 mg
White, round, 11 mm
Used for depression and ADHD
-
C 17
Aminocaproic Acid 500 mg
White, round, 13 mm
Used for hemorrhage
-
CN500
Chloroquine Phosphate 500 mg
White, round, 13 mm
Used for rheumatoid arthritis and amoeba infection
-
A65
Everolimus 5 mg
White, round, 12 mm
Used for seizures
-
AA 99
Nadolol 80 mg
White, round, 11 mm
Used for high blood pressure and heart failure
-
IP 271
Sulfamethoxazole and Trimethoprim 400 mg / 80 mg
White, round, 13 mm
Used for urinary tract infections (UTIs)
Other Buprenorphine and Naloxone pills
-
RP n2
Buprenorphine and Naloxone 2 mg / 0.5 mg
Orange, round, 6 mm
Used for opioid use disorder
Schedule III
-
A 14
Buprenorphine and Naloxone 2 mg / 0.5 mg
Orange, round, 6 mm
Used for opioid use disorder
Schedule III
-
RP n8
Buprenorphine and Naloxone 8 mg / 2 mg
Orange, round, 11 mm
Used for opioid use disorder
Schedule III
-
AN 415
Buprenorphine and Naloxone 8 mg / 2 mg
Orange, round, 11 mm
Used for opioid use disorder
Schedule III
- 7 Buprenorphine Hydrochloride and Naloxone Hydrochloride 0.7 mg / 0.18 mg White, oval, 7 mm Used for opioid use disorder Schedule III
- 1 4 Buprenorphine Hydrochloride and Naloxone Hydrochloride 1.4 mg / 0.36 mg White, triangle, 7 mm Used for opioid use disorder Schedule III
- 11 4 Buprenorphine Hydrochloride and Naloxone Hydrochloride 11.4 mg / 2.9 mg White, oval, 7 mm Used for opioid use disorder Schedule III
- 11 4 Buprenorphine Hydrochloride and Naloxone Hydrochloride 11.4 mg / 2.9 mg White, capsule, 7 mm Used for opioid use disorder Schedule III